Bilayer Heterogeneous Methacrylated Silk Fibroin Scaffold with Antibacterial and Osteoinductive Functions for
Zhuojun Xie1,2, Mengqi Luo1,2, Wenjie Zhang3
1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, P. R. China.
ACS Applied Materials & Interfaces
|October 9, 2025
Summary
This study introduces a novel bilayer hydrogel scaffold for infectious bone defects. The DSHM scaffold effectively controls infection and promotes bone regeneration, offering a promising clinical solution.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Orthopedic Surgery
Background:
- Infectious bone defects (IBDs) present a dual challenge: controlling infection and regenerating bone.
- Guided bone regeneration (GBR) using multifunctional scaffolds is a key strategy for IBD treatment.
- Existing treatments often struggle to simultaneously address infection and bone loss effectively.
Purpose of the Study:
- To develop and characterize a novel bilayer hydrogel scaffold (DSHM) for treating IBDs.
- To integrate antibacterial and osteogenic properties into a single scaffold system.
- To evaluate the DSHM scaffold's efficacy in infection control and bone regeneration.
Main Methods:
- Fabrication of a bilayer hydrogel scaffold (DSHM) using methacrylated silk fibroin (SilMA), hydroxyapatite (HA), and minocycline hydrochloride (MH).
- Optimization of scaffold architecture with a porous HA-loaded layer (PSH) and a dense MH-loaded layer (DSM).
- Assessment of scaffold properties including mechanical strength, degradation, biocompatibility, antibacterial activity, and osteogenic potential.
Main Results:
- The DSHM scaffold exhibited a well-defined bilayer structure with enhanced mechanical properties and tunable degradation.
- The scaffold demonstrated effective inhibition of fibroblast infiltration and sustained antibacterial effects.
- Significant promotion of bone tissue regeneration and osteogenic differentiation was observed in vitro and in vivo.
- The DSHM scaffold showed excellent biocompatibility and synergistic multifunctionality.
Conclusions:
- The developed DSHM scaffold offers a robust and multifunctional approach for treating infectious bone defects.
- The scaffold's design addresses the critical need for simultaneous infection control and bone regeneration.
- The DSHM scaffold shows strong potential for clinical translation in managing IBDs.


